New Extramural Funding

Updated: June 27, 2018

Following is a list of the most recently announced cancer-focused extramural funding opportunities. Please refer to our Upcoming Funding page for additional funding opportunities.

 

National Institutes of Health

Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R01 Clinical Trial Optional) — Application Deadline: 6/29/18

Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R21 Clinical Trials Optional) — Application Deadline: 6/29/18

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research — Application Deadline: 6/27/18

• (R01 Clinical Trial Optional)
• (R21 Clinical Trial Optional)

Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed) — Application Deadline: 6/30/18

Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed) — Application Deadline: 6/30/18

Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed) — Application Deadline: 7/1/18

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) — Application Deadline: 7/5/18

Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01) — Application Deadline: 7/5/18

Obesity Policy Evaluation Research (R01) — Application Deadline: 7/5/18

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) — Application Deadline: 7/5/18

Imaging and Biomarkers for Early Detection of Aggressive Cancer (U01) —  Application Deadline: 7/10/18

Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention — Application Deadline: 7/11/18

• (R01 Clinical Trial Not Allowed)
• (R21 Clinical Trial Not Allowed)

Mechanisms and Consequences of Sleep Disparities in the U.S. (R21) — Application Deadline: 7/11/18

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01) — Application Deadline: 7/11/18

Inter-organelle Communication in Cancer (R01) — LOI Deadline: 7/15/18   Application Deadline: 8/15/18

Inter-organelle Communication in Cancer (R21) — LOI Deadline: 7/15/18   Application Deadline: 8/15/18

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)— LOI Deadline: 7/15/18   Application Deadline: 8/15/18

Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03) — Application Deadline: 7/16/18

Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21) — Application Deadline: 7/16/18

 

American Association for Cancer Research

AACR-Bayer Innovation and Discovery Grants — Application Deadline: 6/29/18

 

Oncology Nursing Society

Research Career Development Award — Application Deadline: 7/1/18

 

Hope Foundation

SWOG Early Exploration and Development (SEED) Fund — Application Deadline: 7/1/18

 

Mesothelioma Applied Research Foundation

Mesothelioma Research Grants — LOI Deadline: 7/1/18

 

Damon Runyon Cancer Research Foundation

Damon Runyon-Rachleff Innovation Award — Application Deadline: 7/6/18

 

Department of Defense – Congressionally Directed Medical Research Programs (CDMRP)

Lung Cancer Research Program: Idea Development Award — LOI Deadline: 7/10/18

Lung Cancer Research Program: Investigator-Initiated Translational Research Award — LOI Deadline: 7/10/18

Lung Cancer Research Program: Translational Research Partnership Award — LOI Deadline: 7/10/18

Lung Cancer Research Program: Concept Award — LOI Deadline: 7/26/18